arrow
V

Vivek Gupta

Macquarie University
H指数:72
被引数:5.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Smart Lipid-Based Nanocarrier System for the Topical Delivery of Ocular Therapeutics Bio-Interfacing, Physicochemical Diversity, and Routing Barriers

脂质基纳米载体系统用于眼用制剂的局部递送:生物界面、物理化学多样性及路由屏障

2026-03-180
OAAI
Quantitative Proteomics Reveal Region-Specific Alterations in Neuroserpin-Deficient Mouse Brain and Retina: Insights into Serpini1 Function

定量蛋白质组学揭示神经丝蛋白缺乏小鼠脑和视网膜的区域特异性改变:Serpini1功能见解

2025-08-220
PRE
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021

1990—2021年与年龄相关性黄斑变性相关的视力损害全球负担,以及至2050年的预测:一项针对2021年全球疾病负担研究的系统分析

2025-06-250
OA
Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research

额颞叶痴呆的生物医学研究差距: 呼吁多样性和差异集中研究

2024-11-130
OAAI
Alzheimer's disease pathophysiology in the Retina

视网膜中的阿尔茨海默病病理生理学

2024-07-017
OAAI
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家在实现世卫组织终结结核病战略的2020里程碑方面取得的进展: 对全球疾病负担研究2021的系统分析

2024-07-0111
OAAI
Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study

澳大利亚70岁及以上成年人的预期寿命、死亡率和疾病负担: 全球疾病负担2019研究的系统分析

2024-06-010
OAAI
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI